VitAL: Viterbi algorithm for de novo peptide design.

<h4>Background</h4>Drug design against proteins to cure various diseases has been studied for several years. Numerous design techniques were discovered for small organic molecules for specific protein targets. The specificity, toxicity and selectivity of small molecules are hard problems...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: E Besray Unal, Attila Gursoy, Burak Erman
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2010
Materias:
R
Q
Acceso en línea:https://doaj.org/article/fd2c529eea6c4e20b0c42fc1021c6d42
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fd2c529eea6c4e20b0c42fc1021c6d42
record_format dspace
spelling oai:doaj.org-article:fd2c529eea6c4e20b0c42fc1021c6d422021-12-02T20:21:13ZVitAL: Viterbi algorithm for de novo peptide design.1932-620310.1371/journal.pone.0010926https://doaj.org/article/fd2c529eea6c4e20b0c42fc1021c6d422010-06-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20532195/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Drug design against proteins to cure various diseases has been studied for several years. Numerous design techniques were discovered for small organic molecules for specific protein targets. The specificity, toxicity and selectivity of small molecules are hard problems to solve. The use of peptide drugs enables a partial solution to the toxicity problem. There has been a wide interest in peptide design, but the design techniques of a specific and selective peptide inhibitor against a protein target have not yet been established.<h4>Methodology/principal findings</h4>A novel de novo peptide design approach is developed to block activities of disease related protein targets. No prior training, based on known peptides, is necessary. The method sequentially generates the peptide by docking its residues pair by pair along a chosen path on a protein. The binding site on the protein is determined via the coarse grained Gaussian Network Model. A binding path is determined. The best fitting peptide is constructed by generating all possible peptide pairs at each point along the path and determining the binding energies between these pairs and the specific location on the protein using AutoDock. The Markov based partition function for all possible choices of the peptides along the path is generated by a matrix multiplication scheme. The best fitting peptide for the given surface is obtained by a Hidden Markov model using Viterbi decoding. The suitability of the conformations of the peptides that result upon binding on the surface are included in the algorithm by considering the intrinsic Ramachandran potentials.<h4>Conclusions/significance</h4>The model is tested on known protein-peptide inhibitor complexes. The present algorithm predicts peptides that have better binding energies than those of the existing ones. Finally, a heptapeptide is designed for a protein that has excellent binding affinity according to AutoDock results.E Besray UnalAttila GursoyBurak ErmanPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 5, Iss 6, p e10926 (2010)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
E Besray Unal
Attila Gursoy
Burak Erman
VitAL: Viterbi algorithm for de novo peptide design.
description <h4>Background</h4>Drug design against proteins to cure various diseases has been studied for several years. Numerous design techniques were discovered for small organic molecules for specific protein targets. The specificity, toxicity and selectivity of small molecules are hard problems to solve. The use of peptide drugs enables a partial solution to the toxicity problem. There has been a wide interest in peptide design, but the design techniques of a specific and selective peptide inhibitor against a protein target have not yet been established.<h4>Methodology/principal findings</h4>A novel de novo peptide design approach is developed to block activities of disease related protein targets. No prior training, based on known peptides, is necessary. The method sequentially generates the peptide by docking its residues pair by pair along a chosen path on a protein. The binding site on the protein is determined via the coarse grained Gaussian Network Model. A binding path is determined. The best fitting peptide is constructed by generating all possible peptide pairs at each point along the path and determining the binding energies between these pairs and the specific location on the protein using AutoDock. The Markov based partition function for all possible choices of the peptides along the path is generated by a matrix multiplication scheme. The best fitting peptide for the given surface is obtained by a Hidden Markov model using Viterbi decoding. The suitability of the conformations of the peptides that result upon binding on the surface are included in the algorithm by considering the intrinsic Ramachandran potentials.<h4>Conclusions/significance</h4>The model is tested on known protein-peptide inhibitor complexes. The present algorithm predicts peptides that have better binding energies than those of the existing ones. Finally, a heptapeptide is designed for a protein that has excellent binding affinity according to AutoDock results.
format article
author E Besray Unal
Attila Gursoy
Burak Erman
author_facet E Besray Unal
Attila Gursoy
Burak Erman
author_sort E Besray Unal
title VitAL: Viterbi algorithm for de novo peptide design.
title_short VitAL: Viterbi algorithm for de novo peptide design.
title_full VitAL: Viterbi algorithm for de novo peptide design.
title_fullStr VitAL: Viterbi algorithm for de novo peptide design.
title_full_unstemmed VitAL: Viterbi algorithm for de novo peptide design.
title_sort vital: viterbi algorithm for de novo peptide design.
publisher Public Library of Science (PLoS)
publishDate 2010
url https://doaj.org/article/fd2c529eea6c4e20b0c42fc1021c6d42
work_keys_str_mv AT ebesrayunal vitalviterbialgorithmfordenovopeptidedesign
AT attilagursoy vitalviterbialgorithmfordenovopeptidedesign
AT burakerman vitalviterbialgorithmfordenovopeptidedesign
_version_ 1718374145725562880